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Valorisation addendum 
 
The aim of clinical research is to ultimately improve patient care. Research 
questions often arise from health care itself. Physicians hope that these patients 
will benefit the most from new research findings. Nevertheless, clinical research 
does also benefit others in society. This valorisation addendum will discuss ways 
to capitalize on the scientific knowledge discussed in this thesis.  
Valorisation as defined by the The National Valorisation Committee:  
“the process of creating value from knowledge, by making knowledge suitable 
and/or available for social and/or economic use and by making knowledge suitable 
for translation into competitive products, services, processes and new activities” 
(Waardevol - Indicatoren voor Valorisatie 2011(1)) 
 
Relevance 
Epilepsy affects about 41-187/100.000 children per year (2). Being diagnosed with 
epilepsy is accompanied by many uncertainties, such as, seizure reoccurrence, 
treatment success and possible therapeutic side effects. In addition, psychosocial 
and socio-economic factors also play a role. For example, fears regarding the 
unpredictability of seizures, developing a low self-esteem, the need for special 
education and problems in family adjustment. Furthermore, in some children, the 
question arises whether possible effects on cognition and/or behavior may impact 
academic achievement as cognitive deficits, educational underachievement and 
behavioral problems are more common among some patients with epilepsy (3, 4).  
To be able to improve care in patients with epilepsy it is necessary to better 
understand cognitive abilities and brain development in patients with epilepsy. 
This thesis focused on two epilepsy syndromes, namely absence epilepsy and 
Panayiotopoulos syndrome. 
 
Findings 
Neurodevelopment and neurocognitive co-morbidities in allegedly benign 
epilepsy syndromes, such as absence epilepsy and Panayiotopoulos syndrome, are 
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far less researched, but may have an impact on academic, behavioral and overall 
development.  In this thesis we have shown that both AE and PS show 
neurocognitive weaknesses in a wide variety of domains, although as a group 
average performance mostly falls within the average range. In AE, attentional 
deficits are the most pronounced cognitive weakness, but up to half show an 
improvement over time. On the other hand, cognitive weaknesses in other 
cognitive domains seem to persist. A lower myelin content in the frontal lobe of 
children with AE may suggest differences in the neurodevelopment of children 
with epilepsy. This thesis, contributes to the knowledge on the neurocognitive 
aspects of epilepsy, which is helpful to improve counseling and treatment 
strategies. 
 
Target groups 
The results of this thesis are relevant for people involved in the care of children 
with absence epilepsy or Panayiotopoulos syndrome such as, (child)neurologists, 
epileptologist, (neuro)psychologists, paediatricians, and general practitioners. 
Awareness of cognitive problems in children with epilepsy enables health care 
professionals to watch out for a possible neurocognitive co-morbidity or academic 
underachievement, so that children can be referred as soon as possible. For 
neuropsychologists, knowledge on the cognitive functions most likely affected is 
valuable to be able to perform the necessary neuropsychological tests. 
Furthermore, this thesis may be relevant to those involved in the academic careers 
of these children, such as teachers, orthopedagogues or people providing special 
education for children with epilepsy In the Netherlands educational counsellors of 
the LWOE (Landelijk Werkverband Onderwijs en Epilepsy) are involved in the 
guidance of children with epilepsy and their teachers to optimize school 
achievements.  
Next, our findings are useful for people involved in epilepsy research, such as 
people writing on consensus articles, such as guidelines for epilepsy syndrome 
classification. The research described in this thesis contradicts that absence 
epilepsy and Panayiotopoulos syndrome are benign epilepsy syndromes at least 
partly due to the neurocognitive co-morbidity as discussed throughout this thesis. 
It has led to a better understanding of the neurocognitive development of 
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children with absence epilepsy and Panayiotopoulos syndrome. As discussed in 
chapter 6, the International League Against Epilepsy (ILAE) has proposed to 
replace the term benign by “self-limited” and “pharmacoresponsive” (5). However, 
the impact on cognitive performance and possible consequences on academic 
achievement should also be formally recognized.  
It may be useful for institutions involved in funding scientific research. 
Additionally, it may help policy makers and health insurances to justify funds for 
adequate neuropsychological follow-up and academic support programs (such as 
the LWOE). Parents and patients with absence epilepsy or Panayiotopoulos 
syndrome may want to know to what extent it may have an impact on cognitive 
performance. For parents, it is important to not simply dismiss absence epilepsy 
and Panayiotopoulos as a benign epilepsy type “which they will outgrow”, as this 
may lead to false expectations in at least a proportion of children. 
 
Knowlegde translation 
A prerequisite for the implementation of new scientific knowledge is 
communicating this knowledge to the scientific community and making it 
available for the public. Therefore, the chapters in this thesis were published in 
international peer-reviewed journals. Furthermore, the results were discussed 
during (poster)presentations and at (inter)national symposia (such as a yearly 
international symposium at epilepsy centre Kempenhaeghe). Moreover, a case 
presentation and discussion was published in a Dutch journal (Epilepsie Periodiek 
voor professionals). In addition, we have given participating children and parents 
information on the results of the study.  
 
Implementation and future work 
Although the used methods and neuropsychological tests are not routine care for 
every child with absence epilepsy or Panayiotopoulos syndrome, and a cost-
effectivness study has not been performed, it does provide necessary insight for 
further development of follow-up protocols. Therefore, our findings can be used 
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to improve clinical practice and neuropsychological follow-up in these children. 
Other clinical implications have been discussed in chapter 6. 
This thesis may inspire new research and businesses (for example involved in the 
development of neuropsychological tools) to develop new diagnostic measures 
and treatments specifically made for children with epilepsy. Myelin imaging may 
be a used as a prognostic tool in the follow-up of children with epilepsy. As myelin 
imaging is a very novel imaging technique in epilepsy research, our methodology 
and findings warrant further imaging studies focusing on myelin and epilepsy. 
Nevertheless, it is still too early to predict the relevance of these findings on a 
larger scale such as how this will improve the care of children with epilepsy. In the 
future, more research on myelinisation patterns of children with epilepsy is 
needed to explore how this relates to neurodevelopmental problems and if this 
may be a core pathophysiological process to which treatment could be developed. 
More recommendations for future research are described in chapter 6. 
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